science

Relfovetmab

Relfovetmab is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Relfovetmab rather than just read about it. In short: Relfovetmab, sold under the brand name Portela, is a felinized monoclonal antibody for the alleviation of pain associated with osteoarthritis in cats. Relfovetmab targets nerve growth factor.

Key takeaways

Relfovetmab belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Relfovetmab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Relfovetmab from memory before moving on to harder problems.

Reference excerpt

Relfovetmab, sold under the brand name Portela, is a felinized monoclonal antibody for the alleviation of pain associated with osteoarthritis in cats. Relfovetmab targets nerve growth factor. Nerve growth factor binds to TrkA receptors located on immune cells to elicit the release of additional proinflammatory mediators, including nerve growth factor itself. These inflammatory mediators lead to further peripheral sensitization involved in pain perception. The inhibition of nerve growth factor was demonstrated to provide relief from pain associated with osteoarthritis. Relfovetmab was authorized for veterinary use in the European Union in October 2025, and in Canada in December 2025.

Medical uses Relfovetmab is indicated for the alleviation of pain associated with osteoarthritis in cats.

Society and culture

Legal status In September 2025, the Committee for Veterinary Medicinal Products of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the veterinary medicinal product Portela, solution for injection, intended for cats. The applicant for this veterinary medicinal product is Zoetis Belgium. Relfovetmab was authorized for veterinary use in the European Union in October 2025. Relfovetmab was authorized for veterinary use in Canada in December 2025.

Names Relfovetmab is the international nonproprietary name. Relfovetmab is sold under the brand name Portela.

References

External links "Relfovetmab ( Code - C174722 )". EVS Explore. Retrieved 28 September 2025.

Worked examples

Example 1 — a first encounter with Relfovetmab

Start with the simplest possible case. Write down what Relfovetmab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Relfovetmab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Relfovetmab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Relfovetmab

In research: Relfovetmab appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Relfovetmab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Relfovetmab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Cat medications, Monoclonal antibodies, so understanding it makes those chapters shorter.
In everyday life: Look for Relfovetmab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Relfovetmab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Relfovetmab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Relfovetmab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Relfovetmab in simple terms?

Relfovetmab, sold under the brand name Portela, is a felinized monoclonal antibody for the alleviation of pain associated with osteoarthritis in cats. Relfovetmab targets nerve growth factor.

Why does Relfovetmab matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Relfovetmab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Relfovetmab.